Page 9 - ஸ்வீடந் இருக்கலாம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Elicera Therapeutics’ first day to subscribe ahead of the listing at Nasdaq First North Growth Market Elicera Therapeutics Publicerad: 24 maj 2021, 08:30 THIS PRESS RELEASE MAY NOT BE MADE PUBLIC, PUBLISHED OR DISTRIBUTED, DIRECTLY OR INDIRECTLY IN OR INTO AUSTRALIA, HONG KONG, JAPAN, CANADA, NEW ZEALAND, SOUTH AFRICA, SOUTH KOREA, SWITZERLAND, SINGAPORE, THE UNITED STATES OR ANY OTHER JURISDICTION WHERE SUCH ACTION IS SUBJECT IN WHOLE OR IN PART TO LEGAL RESTRICTIONS. THIS PRESS RELEASE DOES NOT CONSTITUTE AN OFFER TO ACQUIRE SECURITIES IN ELICERA THERAPEUTICS AB. SEE ALSO THE IMPORTANT INFORMATION SECTION BELOW.          Gothenburg, Sweden May 24, 2021 - Elicera Therapeutics, a clinical stage cell and gene therapy company that develops immunooncological treatments focusing on CAR T cells and oncolytic viruses, announces that the subscription period for the company s new share issue prior to the planned listing on Nasdaq First North Growth Market begins today and

United statesVastra gotalands lanSouth africaSouth koreaJamal el moslehSweden mayNasdaq first north growth marketOncolytic virusElicera therapeuticsஒன்றுபட்டது மாநிலங்களில்தெற்கு கொரியாஸ்வீடந் இருக்கலாம்நாஸ்டாக் முதல் வடக்கு வளர்ச்சி சந்தை